Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 52
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT02633527 | Efficacy and Safety of SPN-812 (Viloxazine Extended-release Capsule) in Children With ADHD | ||
| NCT03638466 | Exploratory fMRI Study on the Treatment for Impulsive Aggression in Children With Attention-Deficit/Hyperactivity Disorder | ||
| NCT02691182 | Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 4) | ||
| NCT06259331 | Evaluation of Viloxazine and Its Metabolite 5-Hydroxy-viloxazine Glucuronide Into Breast Milk in Healthy Lactating Women | ||
| NCT01364662 | A Study to Evaluate the Efficacy and Safety of SPN-810 as Adjunctive Therapy in Children With Impulsive Aggression Comorbid With Attention-Deficit/Hyperactivity Disorder (ADHD) | ||
| NCT04781140 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Preschool-age Children With ADHD | ||
| NCT04016792 | Classroom Study of SPN-812 in Children With ADHD | ||
| NCT04099667 | Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Lower Limb Spasticity | ||
| NCT02549573 | Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN® | ||
| NCT01246765 | National Pregnancy Registry for Psychiatric Medications | ||
| NCT04815967 | Efficacy and Safety Study of MYOBLOC® in the Treatment of Adult Upper Limb Spasticity | ||
| NCT05152680 | Mass Balance Study of NV-5138 in Healthy Male Subjects. | ||
| NCT03156439 | Bioavailability, Safety, and Tolerability of BIS-001 ER | ||
| NCT03247530 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Children With ADHD | ||
| NCT06798896 | RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults with Focal Onset Seizures | ||
| NCT01107496 | Evaluation of Immediate-Release Viloxazine in Adults With ADHD | ||
| NCT05066672 | Phase 2 Study of NV-5138 in Adults With Treatment Resistant Depression | ||
| NCT02610868 | Open-Label and Single-Arm Study of MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adults | ||
| NCT02618434 | Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 2) | ||
| NCT00918424 | Long Term Study of the Safety of OXC XR as in Pediatric Epilepsy Subjects | ||
| NCT02618408 | Treatment of Impulsive Aggression in Subjects With ADHD in Conjunction With Standard ADHD Treatment (CHIME 1) | ||
| NCT02339064 | Infusion of Apomorphine: Long-term Safety Study | ||
| NCT00626236 | Phase 2a Study of Safety and Tolerability of SPN-810 in Children With ADHD and Persistent Serious Conduct Problems | ||
| NCT01284530 | Evaluation of the Pharmacokinetics, Safety, and Tolerability of TPM XR as Adjunctive Therapy in Pediatric Subjects With Epilepsy | ||
| NCT04143217 | Open-label Long-Term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD | ||
| NCT03247517 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) Low Dose in Adolescents With ADHD | ||
| NCT03247543 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Children With ADHD | ||
| NCT03474770 | BIS-001-ER for the Treatment of Adult Focal Impaired Awareness Seizures | ||
| NCT02023606 | Phase I Study to Assess the Absorption, Metabolism, and Excretion of [14C] Labeled SPN-810M | ||
| NCT00908349 | Safety and Tolerability of OXC XR as Adjunctive Therapy in Subjects With Refractory Partial Epilepsy | ||
| NCT01416064 | Open-Label, Extension Study to 810P202 | ||
| NCT04786990 | Open-Label Study of SPN-812 Administered With Psychostimulants in Children and Adolescents With ADHD | ||
| NCT00772603 | Evaluation of Efficacy and Safety of OXC XR as Adjunctive Therapy for Partial Seizures | ||
| NCT04016779 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD | ||
| NCT03615703 | Functional MRI Study in Healthy Children Engaged in Aggressive Behaviors | ||
| NCT03597503 | Treatment of Impulsive Aggression (IA) in Adolescent With ADHD in Conjunction With Standard ADHD Treatment | ||
| NCT05097079 | Efficacy and Safety Study of MYOBLOC in the Treatment of Sialorrhea in Pediatric Subjects | ||
| NCT05102552 | Evaluating the Safety and Relative Bioavailability of Three SPN-817 Treatments (A, B and C) in Healthy Adult Subjects | ||
| NCT06185985 | Open-label Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) in Adults With ADHD and Mood Symptoms | ||
| NCT03280342 | Cognitive Effects of Immediate Release Topiramate vs Extended Release Topiramate in Patients With Migraine | ||
| NCT01994109 | Efficacy and Safety Study of MYOBLOC® Followed by Open-Label Multiple-Treatment With MYOBLOC® in the Treatment of Troublesome Sialorrhea in Adult Subjects | ||
| NCT03944785 | Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide) | ||
| NCT03247556 | Evaluation of SPN-812 (Viloxazine Extended-release Capsule) High Dose in Adolescents With ADHD | ||
| NCT04050293 | Therapy for Migraine Prevention in Children 6-11 Years of Age | ||
| NCT02736656 | Open-label Study to Evaluate Long-term Safety and Efficacy of SPN-812 (Viloxazine Extended-release Capsule) | ||
| NCT01085461 | Assessment of Suicidality in Epilepsy - Rating Tools | ||
| NCT05518578 | Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy | ||
| NCT06235905 | Open-Label of SPN-820 in Adults With Major Depressive Disorder | ||
| NCT05384977 | Mass Balance Study of NV-5138 in Healthy Male Subjects | ||
| NCT00918047 | Study of PK and Safety of OXC (Oxcarbazepine) XR (Extended Release) as Adjunctive Therapy in Pediatric Epilepsy Patients |
